NCATS Funds New Drug Repurposing Projects

NCATS Funds New Drug Repurposing Projects, Seeks Additional ...

NCATS recently awarded funding for three new projects to repurpose compounds that have already undergone significant research and development by industry.

NCATS Funding Available to Repurpose Existing Drugs

NCATS has announced funding opportunities to use partially developed therapeutic candidates (also known as assets) to identify new treatments for a broad range ...

New Therapeutic Uses | National Center for Advancing Translational ...

Repurposing Off-Patent Drugs Workshop/Drug Repurposing Toolbox ... In December 2019, NCATS, the U.S. Food and Drug Administration (FDA) and the Reagan-Udall ...

NCATS Drug Repurposing

Approved drugs have already been tested in humans, so some repurposed treatments could enter clinical trials much sooner. They also could be approved for new ...

Therapeutics for Rare and Neglected Diseases (TRND) Projects

The Division of Preclinical Innovation has created the NCATS Pharmaceutical Collection, a library of 2,500 approved drugs and 1,000 ...

NCATS Seeks Applications to Repurpose Existing Drugs

... projects that are based on repurposing existing drugs or biologics. Through this new funding opportunity, NCATS anticipates committing $4.3 ...

Large Clinical Trial to Study Repurposed Drugs to Treat COVID-19 ...

NIH will provide an initial investment of $155 million in funding for the trial. ... “Getting approval for a new drug to come to market ...

NCATS Launches Drug Repurposing Project with Big Pharma ...

To kick off the Discovering New Therapeutic Uses for Existing Molecules program, NCATS plans to release a new funding opportunity sometime ...

CURE Drug Repurposing Collaboratory - Critical Path Institute

In response to these challenges, the CURE Drug Repurposing Collaboratory (CDRC) was founded to explore whether already marketed drugs can be repurposed for ...

NCATS Awards $12.7M for Nine Drug Repurposing Projects

NIH's National Center for Advancing Translational Sciences (NCATS) awarded a total $12.7 million to nine academic research groups toward ...

Our Impact on Drug Discovery and Development

Navigation · Moving More Treatments from the Lab to the Clinic · Impact Stories · Drug Repurposing Reveals HIV Drug Shows Promise for Muscle Disorder · Tiny ...

NCATS launches drug repurposing program - ResearchGate

In the United States, the National Center for Advancing Translational Sciences (NCATS) de nes drug repurposing as the investigation of drugs already approved ...

NCATS Pharmaceutical Collection

We developed a new OpenData Portal to share COVID-19-related drug repurposing data and experiments for all approved drugs. To develop the ...

NCATS Announces Funding Opportunities to Repurpose Industry…

NCATS Announces Funding Opportunities to Repurpose Industry Drug Candidates ... Researchers can crowdsource ideas for new therapeutic uses. May 12 ...

The NIH's Drug Repurposing Initiative: Will It Be a Waste? - Science

NIH is putting up $20 million for grants to study the drugs. "The goal is simple: to see whether we can teach old drugs new tricks," said Health ...

NCATS Announces Funding Opportunities to Repurpose Existing ...

NCATS is seeking applications through its NIH-Industry Partnerships initiative to explore new treatments for experimental drugs.

NIH Announces Nine Projects to Repurpose Old Drugs | Science

The program, called Discovering New Therapeutic Uses for Existing Molecules, aims to help companies work with academic researchers to repurpose ...

NCATS Seeks Applications to Repurpose Existing Drugs - MDedge

NCATS Seeks Applications to Repurpose ... projects based on repurposing existing drugs or biologics through a new funding opportunity.

Discovering New Therapeutic Uses for Existing Molecules

By repurposing an existing drug, investigators began testing the drug in ... ncats.nih.gov/ntu/projects. Funding Information ncats.nih.gov/ntu/funding.

Funding available to repurpose existing drugs - ITHS

Biologics are available through NCATS-Pharmaceutical partnerships and the New Therapeutic Uses program. This program facilitates academic-industry ...